HealthTell Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
6
HealthTell General Information
Description
Provider of an immune profiling technology intended to provide accurate and affordable diagnostic for early disease detection. The company provides diverse chemical libraries that are deployed to offer unique insights into the universe of biomolecular interactions and use a proprietary immune profiling technology to analyze the immune system's response against diseases, thereby enabling drug discovery institutes to get new insights about important diseases such as autoimmune, cancer, central nervous system and infectious diseases.
Contact Information
Website
www.healthtell.comCorporate Office
- 2420 Camino Ramon
- Suite 125
- San Ramon, CA 94583
- United States
Corporate Office
- 2420 Camino Ramon
- Suite 125
- San Ramon, CA 94583
- United States
HealthTell Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HealthTell Comparisons
Industry
Financing
Details
HealthTell Competitors (43)
One of HealthTell’s 43 competitors is Personal Genome Diagnostics, a Formerly VC-backed company based in Baltimore, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD | ||||
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| ProSci (Biotechnology) | Private Equity-Backed | Poway, CA | ||||
| Adaptyv | Venture Capital-Backed | Lausanne, Switzerland | ||||
| Dren Bio | Venture Capital-Backed | San Carlos, CA |
HealthTell Patents
HealthTell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220010301-A1 | Methods of selecting functional interface mimics, and compositions thereof | Inactive | 14-Nov-2018 | ||
| WO-2020102365-A1 | Methods of selecting functional interface mimics, and compositions thereof | Inactive | 14-Nov-2018 | ||
| WO-2019209874-A2 | Markers of immune wellness and methods of use thereof | Inactive | 24-Apr-2018 | ||
| WO-2019209874-A3 | Markers of immune wellness and methods of use thereof | Inactive | 24-Apr-2018 | ||
| WO-2019157362-A1 | Array-based cyclic peptide libraries | Inactive | 09-Feb-2018 | C07K17/14 |
HealthTell Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HealthTell FAQs
-
When was HealthTell founded?
HealthTell was founded in 2010.
-
Where is HealthTell headquartered?
HealthTell is headquartered in San Ramon, CA.
-
What industry is HealthTell in?
HealthTell’s primary industry is Discovery Tools (Healthcare).
-
Is HealthTell a private or public company?
HealthTell is a Private company.
-
What is HealthTell’s current revenue?
The current revenue for HealthTell is .
-
How much funding has HealthTell raised over time?
HealthTell has raised $43.6M.
-
Who are HealthTell’s investors?
Acadia Woods Partners, BlueTree Allied Angels, Cambridge Global Advisors, National Cancer Institute, and Paladin Capital Group are 5 of 12 investors who have invested in HealthTell.
-
Who are HealthTell’s competitors?
Personal Genome Diagnostics, Deep Genomics, ProSci (Biotechnology), Adaptyv, and Dren Bio are some of the 43 competitors of HealthTell.
-
When was HealthTell acquired?
HealthTell was acquired on 06-Jun-2018.
-
Who acquired HealthTell?
HealthTell was acquired by iCarbonX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process